Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
BMY
BMY
NYSE
Health Technology
Pharmaceuticals: Major
63.00
USD
+1.88
+3.08%
Closed: 10-22 20:00 (UTC+0)
63.39
USD
+0.39
+0.62%
After Hours: 10-23 00:00 (UTC+0)

BMY Key Statistics

High
63.59
Open
61.46
Volume
15.16M
Low
61.04
Prev. Close
61.12
Trading Value
954.11M
52-Week High
68.64
Relative Volume
1.599
Amplitude (%)
4.17%
52-Week Low
42.52
Turnover Rate
0.74%
Market Cap
128.69B
P/E Ratio (TTM)
13.46
P/E Ratio (Annual)
17.614
P/B Ratio
5.59
P/S Ratio
2.54
Earnings Per Share (EPS)
4.539
Dividend (TTM)
2.494
Dividend Yield
4.07%
Shares Outstanding
2.04B
Currency Unit
USD

BMY Price Performance

7 day
30 day
90 day
180 day
Year to date
1 Year
BMY Money Flow Distribution
BMY Daily Short Sale Volume
BMY Short Interest History
As of 2026-10-23, the Bristol-Myers Squibb Company (BMY) stock price today is 63. Based on this price, the company has a market capitalization of $128.69B, with a P/E ratio of 13.46. On 2026-10-23, BMY traded between 61.04 and 63.59. Today’s stock price is 3.21% above the daily low and 0.93% below the daily high, placing BMY in the upper range of its most recent trading range. Trading volume currently stands at 15.16M, compared with an average daily volume of 9.48M. This suggests that trading activity is significantly above its usual level than usual. Over the past year, Bristol-Myers Squibb Company shares have traded between 42.52 and 68.64. At today’s price, BMY is 48.17% above its 52-week low and 8.22% below its 52-week high.
Company Name
Bristol-Myers Squibb Company
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
NYSE
Number of Employees
32,500
Lot Size
100
Official Website
Currency Unit
USD
Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical company that markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

BMY FAQ